Click here to load reader
Upload
scott-fuqua
View
89
Download
0
Embed Size (px)
DESCRIPTION
Sample cost savings analysis for our Pharmacy Price Transparency Tool - a web-based tool for employers and their employees. This will show you the typical ROI that is delivered by this product.
Citation preview
SAMPLE
CLAIMS
REVIEWS
PRELIMINARY ANALYSIS
Relevant Healthcare
Mokena, IL 60448
www.RelevantHealthcare.com
COMPANY ONE REVIEW
Claims Review – COMPANY ONE Relevant Healthcare | 2
Relevant Healthcare has compiled this report outlining potential savings
opportunities for COMPANY ONE on behalf of BROKER, assuming they
implemented our pharamacy transparency solution. Listed below, our findings along
with an example of a simulated transaction using our transparency tool.
COMPANY ONE RESULTS
Average Enrolled 533
Claims period 7/1/13 – 1/31/14
No. of claims 8606
Employer drug spend $567,528 (79%) $972,905 YR $152.11 PEPM
Employee copays/coinsurance $204,995 (21%) $351,317 YR
SAVINGS OPPORTUNITY
Identified opportunity $197,409 (34.8%) $338,415 YR $52.91 PEPM
Cost to COMPANY ONE (36 mo) $6 PEPM
ACTION RATE RETURN ON INVESTMENT
11% BREAK EVEN
20% 76%
30% 164%
40% 252%
50% 340%
SPECIFIC EXAMPLE
A claim for zolpidem tartrate 10MG (90 tablets/90 days) had a member copay of $25
and a company cost of $129.03. Using our program, the same medication may be
purchased from a number of local pharmacies for $8.43 for 90 tablets/90 days with no
cost to the employer. This one example represents an estimated total savings
potential of $516.12 per year in cost avoidance for the company in addition to $66.28
in annual savings for this employee.
Again, we appreciate the opportunity to provide this claims review to you. Should
there be any specific questions we could address, please contact us at
inquiries@RelevantHealthcare or call 855-328-5100.
Kindest Regards,
The Claims Review Team at Relevant Healthcare
COMPANY TWO REVIEW
Claims Review – COMPANY TWO Relevant Healthcare| 3
Relevant Healthcare has compiled this report outlining potential savings
opportunities for COMPANY TWO on behalf of BROKER, assuming they
implemented our pharmacy transparency solution. Listed below, our findings along
with an example of a simulated transaction using our transparency tool.
COMPANY TWO RESULTS
Average Enrolled 500
Claims period 9/1/2012 – 8/31/2013
No. of claims 6761
Employer drug spend $641,977 (79%) $107 PEPM
Employee copays/coinsurance $178.269 (21%)
SAVINGS OPPORTUNITY
Identified opportunity $185,962 (28.9%) $35.10 PEPM
Cost to COMPANY TWO (36 mo) $6 PEPM
ACTION RATE RETURN ON INVESTMENT
16% BREAK EVEN
30% 85%
40% 147%
50% 209%
60% 271%
SPECIFIC EXAMPLE
A claim for escitalopram oxalate 10MG (30 tablets/30 days) had a member copay of
$10 and a company cost of $26.93. Using our program, the same medication may be
purchased from a number of local pharmacies for $12.66 for 90 tablets/90 days with
no cost to the employer. This one example represents an estimated total savings
potential of $323.16 per year in cost avoidance for the company in addition to $69.36
in annual savings for this employee.
Again, we appreciate the opportunity to provide this claims review to you. Should
there be any specific questions we could address, please contact us at
inquires@RelevantHealthcare or call 855-328-5100.
Kindest Regards,
The Claims Review Team at Relevant Healthcare